Recent News

• 11.06.2026 - Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
• 10.26.2026 - Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
• 10.22.2026 - Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
• 10.13.2026 - Canopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-certified Site Combining Softgel Manufacturing with Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
• 09.28.2026 - Canopy Growth Corporation names Sebastian Blöte as Germany country manager
• 09.28.2026 - Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany
• 09.25.2026 - Canopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of Quorum
• 09.23.2026 - Canopy Growth Announces Extension of Proxy Voting Deadline For 2026 Annual General and Special Meeting
• 09.22.2026 - Canopy Growth Expands European Medical Cannabis Supply into the UK
• 09.14.2026 - Canopy Growth Reminds Shareholders to Vote Ahead of September 23 Deadline

Recent Filings

• 11.06.2026 - 8-K Current report
• 11.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2026 - EX-99.1 EX-99.1
• 10.23.2026 - 8-K Current report
• 10.16.2026 - 8-K Current report
• 10.16.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 10.06.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 09.30.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.30.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.30.2026 - 4 Statement of changes in beneficial ownership of securities